Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome. | J Alzheimers Dis | 2024 | 39422950 | PubTator, text mining | PubMed |
| The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA. | PLoS One | 2024 | 39405283 | PubTator, text mining | PubMed |
| Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells. | Sci Rep | 2024 | 39397076 | PubTator, text mining | PubMed |
| A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD). | Bioorg Med Chem | 2024 | 39357433 | PubTator, text mining | PubMed |
| Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B. | J Med Chem | 2024 | 39344427 | PubTator, text mining | PubMed |
| Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia. | Blood | 2024 | 39316649 | PubTator, text mining | PubMed |
| Skeletal health in DYRK1A syndrome. | Front Neurosci | 2024 | 39308945 | PubTator, text mining | PubMed |
| Microtubule-associated protein, MAP1B, encodes functionally distinct polypeptides. | J Biol Chem | 2024 | 39305956 | PubTator, text mining | PubMed |
| Halogen Bonding on Water─A Drop in the Ocean? | J Chem Theory Comput | 2024 | 39291905 | PubTator, text mining | PubMed |
| Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing. | Front Genet | 2024 | 39280100 | PubTator, text mining | PubMed |
| MEK inhibitors in oncology: a patent review and update (2016 - present). | Expert Opin Ther Pat | 2024 | 39275922 | PubTator, text mining | PubMed |
| Regulation of Drosophila brain development and organ growth by the Minibrain/Rala signaling network. | G3 (Bethesda) | 2024 | 39271109 | PubTator, text mining | PubMed |
| Thr4 phosphorylation on RNA Pol II occurs at early transcription regulating 3'-end processing. | Sci Adv | 2024 | 39241064 | PubTator, text mining | PubMed |
| Network Pharmacology Identifies Intersection Genes of Apigenin and Naringenin in Down Syndrome as Potential Therapeutic Targets. | Pharmaceuticals (Basel) | 2024 | 39204195 | PubTator, text mining | PubMed |
| Protocol for the in vitro reconstruction of site-specifically phosphorylated RNA Pol II to identify the recruitment of novel transcription regulators. | STAR Protoc | 2024 | 39196783 | PubTator, text mining | PubMed |
| Network medicine-based epistasis detection in complex diseases: ready for quantum computing. | Nucleic Acids Res | 2024 | 39175109 | PubTator, text mining | PubMed |
| Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions. | Front Mol Neurosci | 2024 | 39114642 | PubTator, text mining | PubMed |
| Discovery of a Novel DYRK1A Mutation (c.524del) in Intellectual Development Disorder Autosomal Dominant 7 (MRD7): A Comprehensive Case Analysis. | Case Rep Genet | 2024 | 39109359 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes. | Bioorg Chem | 2024 | 39068716 | PubTator, text mining | PubMed |
| Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's Disease. | J Med Chem | 2024 | 39041662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=11